The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease

Tricuspid / Pulmonary valve

Endovascular treatments for complications of the tricuspid or pulmonary valve, such as the treatment for tricuspid regurgitation (TR), are at an early stage of clinical development with many novel devices being introduced each year. This topic explores the different parameters of this emerging field with information on the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection.


Search by author
Filter by type
Showing 41-55 of 55 articles
Interventions for valvular disease
Valvular heart disease: the unanswered questions
September 17, 2015 | 10.4244/EIJV11SWA2
Interventions for valvular disease
Multiple valve disease - assessment, strategy and intervention
September 17, 2015 | 10.4244/EIJV11SWA3
Interventions for valvular disease
Measuring risk in valvular interventions: from low risk to futility
September 17, 2015 | 10.4244/EIJV11SWA6
Interventions for valvular disease
Tricuspid valve interventions: surgical techniques and outcomes
September 17, 2015 | 10.4244/EIJV11SWA36
Interventions for valvular disease
Tricuspid valve interventions in 2015
September 17, 2015 | 10.4244/EIJV11SWA37